RCT: Early symptomatic improvement after ustekinumab therapy in patients with ulcerative colitis.
21 Mar, 2022 | 08:26h | UTCEarly symptomatic improvement after ustekinumab therapy in patients with ulcerative colitis: 16-week data from the UNIFI trial – Clinical Gastroenterology and Hepatology (link to abstract – $ for full-text)